Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
16-week randomized study of 5% minoxidil topical gel versus foam and placebo in men with androgenetic alopecia
2017-000613-22Phase 2Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of minoxidil in androgenetic alopecia (AGA) (3 arms), sponsored by Johnson & Johnson. Primary endpoint: Change from baseline in total non-vellus terminal area hair count at week 16. Started Jun 2018; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2017-000613-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000613-22.